iifl-logo-icon 1

Panacea Biotec Ltd Share Price

139.43
(-0.73%)
Jul 12, 2024|03:32:20 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open141.3
  • Day's High143
  • 52 Wk High202.5
  • Prev. Close140.45
  • Day's Low138.01
  • 52 Wk Low112.35
  • Turnover (lac)135.86
  • P/E242.24
  • Face Value1
  • Book Value50.21
  • EPS0.58
  • Mkt. Cap (Cr.)854.02
  • Div. Yield0
No Records Found

Panacea Biotec Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

141.3

Prev. Close

140.45

Turnover(Lac.)

135.86

Day's High

143

Day's Low

138.01

52 Week's High

202.5

52 Week's Low

112.35

Book Value

50.21

Face Value

1

Mkt Cap (₹ Cr.)

854.02

P/E

242.24

EPS

0.58

Divi. Yield

0

Panacea Biotec Ltd Corporate Action

14 Aug 2023

12:00 AM

AGM

Announcement Date: 14 Aug, 2023

arrow

13 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

14 Aug 2023

12:00 AM

BookCloser

arrow

Panacea Biotec Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Panacea Biotec Ltd SHAREHOLDING SNAPSHOT

13 Jul, 2024|07:00 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 73.58%

Foreign: 0.00%

Indian: 73.58%

Non-Promoter- 1.10%

Institutions: 1.10%

Non-Institutions: 25.30%

Custodian: 0.00%

Share Price

Panacea Biotec Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

27.78

27.78

27.78

59.92

Preference Capital

0

0

0

0

Reserves

297.87

387.32

480.39

832.82

Net Worth

325.65

415.1

508.17

892.74

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

343.55

158.08

576.56

530.08

yoy growth (%)

117.32

-72.58

8.76

-18.05

Raw materials

-176.26

-58.52

-196.99

-168.83

As % of sales

51.3

37.02

34.16

31.84

Employee costs

-59.47

-46.64

-136.73

-132.2

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-12.85

-63.52

-61.23

-46.5

Depreciation

-26.57

-26.9

-57.04

-66.14

Tax paid

-1.56

-17.09

-10.64

11.38

Working capital

-357.74

386.41

-54.89

14.93

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

117.32

-72.58

8.76

-18.05

Op profit growth

-100.78

-176.42

17.18

-38.24

EBIT growth

-90.84

-238.73

-26.33

-14.6

Net profit growth

-90.56

112.96

-1.08

-8,451.83

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

559.17

459.95

661.23

624.81

544.06

Excise Duty

0

0

0

0

0

Net Sales

559.17

459.95

661.23

624.81

544.06

Other Operating Income

0

0

0

0

0

Other Income

61.83

154.32

1,687.18

10.06

30.02

Panacea Biotec Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,581.75

124.473,79,874.71867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,582.5

77.171,21,620.455310.652,259507.93

Cipla Ltd

CIPLA

1,506

32.731,21,596.061,038.40.563,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,163.35

33.971,17,155.821,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,594.75

25.681,10,037.531,034.80.615,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Panacea Biotec Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Rajesh Jain

Joint Managing Director

Sandeep Jain

Non-Exec. & Independent Dir.

R L Narasimhan

Non-Exec. & Independent Dir.

N N Khamitkar

Non-Exec. & Independent Dir.

K M Lal

Group CFO & Company Secretary

Vinod Goel

Non-Exec. & Independent Dir.

Manjula Upadhyay

Non-Exec. & Independent Dir.

Mukul Gupta

Whole-time Director

Ankesh Jain

Non-Exec. & Independent Dir.

BHUPINDER SINGH

Non Executive Director

Narotam Kumar Juneja

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Indias leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on 2nd February 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines. The Company has collaborations and tie-ups with leading national and international research organizations and corporations. PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers. The Company also has 24 product patents, valid in more than 60 countries worldwide. The plant for vaccines production (Radicura Pharma) and pharmaceutical formulations plant (Panacea Drug P Ltd) at New Delhi were established during the year 1988 and 1989 respectively. In 1993, merger of Panacea Drugs (P) Ltd and Radicura Pharma gave the name Panacea Biotec Ltd. The Company made its Initial Public Offering (IPO) in the year of 1995 and also in the same year, PBL had formed state -of the- art Drug Delivery R&D centre at Lalru. In the year 1997, th
Read More

Company FAQs

What is the Panacea Biotec Ltd share price today?

Down Arrow

The Panacea Biotec Ltd shares price on N/A is Rs.₹139.85 today.

What is the Market Cap of Panacea Biotec Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Panacea Biotec Ltd is ₹856.59 Cr. as of 12 Jul ‘24

What is the PE and PB ratio of Panacea Biotec Ltd?

Down Arrow

The PE and PB ratios of Panacea Biotec Ltd is 242.24 and 2.61 as of 12 Jul ‘24

What is the 52 Week High and Low of Panacea Biotec Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Panacea Biotec Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Panacea Biotec Ltd is ₹112.7 and ₹202.2 as of 12 Jul ‘24

What is the CAGR of Panacea Biotec Ltd?

Down Arrow

Panacea Biotec Ltd's CAGR for 5 Years at 0.36%, 3 Years at -27.92%, 1 Year at 12.04%, 6 Month at -25.37%, 3 Month at -2.50% and 1 Month at 5.05%.

What is the shareholding pattern of Panacea Biotec Ltd?

Down Arrow

The shareholding pattern of Panacea Biotec Ltd is as follows:
Promoters - 73.59 %
Institutions - 1.11 %
Public - 25.30 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.